The Manila Times

Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

Single dose of powerful psychedelic cuts depression symptoms in clinical study

Breakthrough study finds single dose of psychedelics significantly reduced depression symptoms in clinical trial, with ...

Winter Depression Has Reached Crisis Levels As a Major Winter Storm Threatens Millions, Affecting Kids, Teens, & Adults

How light deprivation, disrupted routines, and severe winter weather are impacting mental health across all ages LAS ...
European Medical Journal

DMT Rapidly Reduces Major Depression Symptoms

DMT therapy significantly reduced major depressive disorder symptoms in a phase IIa trial. Learn more about this rapid-acting ...
Everyday Health on MSN

How to measure real recovery in major depressive disorder

Learn to track real recovery in major depressive disorder by monitoring mood, energy, cognition, and quality of life for ...
Psychology Today

Can Exercise Help Depression? What to Know

A large review adds weight to an old idea: movement can help ease depression. Here’s how to think about exercise as part of ...

What causes depression? What we know, don't know and suspect

Depression is a complex and deeply personal experience. While almost everyone has periods of sadness, low mood or grief, ...

TMS Therapy for Depression: How It Works & Benefits

Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...
Medscape

A Single Dose of Short-Acting Psychedelic Rapidly Eases Major Depression

Dimethyltryptamine’s short duration of psychedelic effects makes it a potentially practical alternative to other longer-acting psychedelic therapies such as psilocybin.

Magic Mushroom Ingredient Passes Major Test, Paving Way for FDA Approval

In two large-scale trials, Compass Pathways' proprietary form of psilocybin improved people's depression symptoms better than controls.

Adding extra salt to your food raises risk of depression by a QUARTER, scientists say

For more than two decades, ­health officials have urged us to reduce our salt intake to slash the UK death toll from heart disease. But now, scientists have warned that frequently adding salt to ...